View Financial HealthSinoma Science & TechnologyLtd 配当と自社株買い配当金 基準チェック /36Sinoma Science & TechnologyLtd配当を支払う会社であり、現在の利回りは0.61%で、収益によって十分にカバーされています。主要情報0.6%配当利回りn/aバイバック利回り総株主利回りn/a将来の配当利回り1.0%配当成長14.6%次回配当支払日n/a配当落ち日n/a一株当たり配当金n/a配当性向37%最近の配当と自社株買いの更新Declared Dividend • May 27Dividend reduced to CN¥0.56Dividend of CN¥0.56 is 15% lower than last year. Ex-date: 31st May 2024 Payment date: 31st May 2024 Dividend yield will be 3.6%, which is higher than the industry average of 2.6%. Sustainability & Growth Dividend is covered by earnings (46% earnings payout ratio) but the company has no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has increased by an average of 28% per year over the past 10 years. However, payments have been volatile during that time. EPS is expected to grow by 66% over the next 3 years, which should provide support to the dividend and adequate earnings cover.お知らせ • May 26Sinoma Science & Technology Co.,Ltd. Announces Final Cash Dividend on A Shares for 2023, Payable on 31 May 2024Sinoma Science & Technology Co.,Ltd. announced 2023 final profit distribution plan to be implemented (A shares): Cash dividend/10 shares (tax included): CNY 5.60000000. Record date: 30 May 2024; Ex-date: 31 May 2024; Payment date: 31 May 2024.お知らせ • May 25Sinoma Science & Technology Co.,Ltd. Announces Final Dividend on A Shares for the Year 2022, Payable on May 31, 2023Sinoma Science & Technology Co.,Ltd. announced final cash dividend/10 shares (tax included) of CNY 6.60000000 on A shares for the year 2022. Record date is May 30, 2023. Ex-date is May 31, 2023. Payment date is May 31, 2023.お知らせ • Mar 20Sinoma Science & Technology Co., Ltd. Announces Profit Distribution Proposal for 2020Sinoma Science & Technology Co., Ltd. announced profit distribution proposal of CNY 4.00000000 per 10 shares (tax included) for 2020.すべての更新を表示Recent updatesBoard Change • May 20Less than half of directors are independentThere are 5 new directors who have joined the board in the last 3 years. Of these new board members, 1 was an independent director. The company's board is composed of: 3 independent directors. 4 non-independent directors. Independent Director Guanyu Wang was the last independent director to join the board, commencing their role in 2024. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of board continuity.お知らせ • Mar 31Sinoma Science & Technology Co.,Ltd. to Report Q1, 2026 Results on Apr 24, 2026Sinoma Science & Technology Co.,Ltd. announced that they will report Q1, 2026 results on Apr 24, 2026お知らせ • Mar 19Sinoma Science & Technology Co.,Ltd., Annual General Meeting, Apr 09, 2026Sinoma Science & Technology Co.,Ltd., Annual General Meeting, Apr 09, 2026, at 16:30 China Standard Time. Location: 12F, Building 7, Yard No. 6, North Street, Dongsheng Science and Technology Park, Haidian District, Beijing Chinaお知らせ • Dec 31Sinoma Science & Technology Co.,Ltd. to Report Fiscal Year 2025 Results on Mar 20, 2026Sinoma Science & Technology Co.,Ltd. announced that they will report fiscal year 2025 results on Mar 20, 2026お知らせ • Sep 30+ 2 more updatesSinoma Science & Technology Co.,Ltd. to Report Q3, 2025 Results on Oct 22, 2025Sinoma Science & Technology Co.,Ltd. announced that they will report Q3, 2025 results on Oct 22, 2025お知らせ • Jul 02Sinoma Science & Technology Co.,Ltd. to Report First Half, 2025 Results on Aug 22, 2025Sinoma Science & Technology Co.,Ltd. announced that they will report first half, 2025 results on Aug 22, 2025お知らせ • Apr 12+ 1 more updateSinoma Science & Technology Co.,Ltd. Approves the Election of Ni Jinrui as DirectorSinoma Science & Technology Co.,Ltd. at its Annual General Meeting held on 10 April 2025 approved the election of Ni Jinrui as a director.お知らせ • Mar 31Sinoma Science & Technology Co.,Ltd. to Report Q1, 2025 Results on Apr 24, 2025Sinoma Science & Technology Co.,Ltd. announced that they will report Q1, 2025 results on Apr 24, 2025お知らせ • Mar 20Sinoma Science & Technology Co.,Ltd., Annual General Meeting, Apr 10, 2025Sinoma Science & Technology Co.,Ltd., Annual General Meeting, Apr 10, 2025, at 16:30 China Standard Time. Location: The Company's Meeting Room, Beijing Chinaお知らせ • Dec 31Sinoma Science & Technology Co.,Ltd. to Report Fiscal Year 2024 Results on Mar 20, 2025Sinoma Science & Technology Co.,Ltd. announced that they will report fiscal year 2024 results on Mar 20, 2025お知らせ • Nov 15Sinoma Science & Technology Co.,Ltd. Appoints Feng Jun as DirectorSinoma Science & Technology Co.,Ltd. held its 4th Extraordinary General Meeting of 2024 on 13 November 2024 were approved; Election of Feng Jun as a director.Reported Earnings • Oct 26Third quarter 2024 earnings released: EPS: CN¥0.086 (vs CN¥0.19 in 3Q 2023)Third quarter 2024 results: EPS: CN¥0.086 (down from CN¥0.19 in 3Q 2023). Revenue: CN¥6.27b (up 7.1% from 3Q 2023). Net income: CN¥143.7m (down 55% from 3Q 2023). Profit margin: 2.3% (down from 5.4% in 3Q 2023). Revenue is forecast to grow 16% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 26% per year whereas the company’s share price has fallen by 30% per year.お知らせ • Sep 30Sinoma Science & Technology Co.,Ltd. to Report Q3, 2024 Results on Oct 25, 2024Sinoma Science & Technology Co.,Ltd. announced that they will report Q3, 2024 results on Oct 25, 2024Valuation Update With 7 Day Price Move • Sep 28Investor sentiment improves as stock rises 22%After last week's 22% share price gain to CN¥11.61, the stock trades at a forward P/E ratio of 12x. Average forward P/E is 16x in the Chemicals industry in China. Total loss to shareholders of 64% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥8.71 per share.Buy Or Sell Opportunity • Sep 26Now 24% overvaluedOver the last 90 days, the stock has fallen 16% to CN¥10.86. The fair value is estimated to be CN¥8.73, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 8.7% over the last 3 years. Earnings per share has declined by 17%. Revenue is forecast to grow by 35% in 2 years. Earnings are forecast to grow by 70% in the next 2 years.お知らせ • Sep 11Sinoma Science & Technology Co.,Ltd. Approves Board ElectionsSinoma Science & Technology Co.,Ltd. at its EGM held on September 9, 2024 approved election of Zhuang Qinxia as director and Wang Guanyu as independent director.Reported Earnings • Aug 22Second quarter 2024 earnings released: EPS: CN¥0.15 (vs CN¥0.58 in 2Q 2023)Second quarter 2024 results: EPS: CN¥0.15 (down from CN¥0.58 in 2Q 2023). Revenue: CN¥6.11b (down 17% from 2Q 2023). Net income: CN¥248.4m (down 75% from 2Q 2023). Profit margin: 4.1% (down from 13% in 2Q 2023). Revenue is forecast to grow 15% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 17% per year but the company’s share price has fallen by 30% per year, which means it is performing significantly worse than earnings.お知らせ • Jun 29Sinoma Science & Technology Co.,Ltd. to Report First Half, 2024 Results on Aug 22, 2024Sinoma Science & Technology Co.,Ltd. announced that they will report first half, 2024 results on Aug 22, 2024Declared Dividend • May 27Dividend reduced to CN¥0.56Dividend of CN¥0.56 is 15% lower than last year. Ex-date: 31st May 2024 Payment date: 31st May 2024 Dividend yield will be 3.6%, which is higher than the industry average of 2.6%. Sustainability & Growth Dividend is covered by earnings (46% earnings payout ratio) but the company has no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has increased by an average of 28% per year over the past 10 years. However, payments have been volatile during that time. EPS is expected to grow by 66% over the next 3 years, which should provide support to the dividend and adequate earnings cover.お知らせ • May 26Sinoma Science & Technology Co.,Ltd. Announces Final Cash Dividend on A Shares for 2023, Payable on 31 May 2024Sinoma Science & Technology Co.,Ltd. announced 2023 final profit distribution plan to be implemented (A shares): Cash dividend/10 shares (tax included): CNY 5.60000000. Record date: 30 May 2024; Ex-date: 31 May 2024; Payment date: 31 May 2024.お知らせ • May 15Sinoma Science & Technology Co.,Ltd. Elects Zhang Wenjin as a DirectorSinoma Science & Technology Co.,Ltd. held its first Extraordinary General Meeting of 2024 on 13 May 2024, elected Zhang Wenjin as a director.Reported Earnings • Apr 26First quarter 2024 earnings released: EPS: CN¥0.13 (vs CN¥0.25 in 1Q 2023)First quarter 2024 results: EPS: CN¥0.13 (down from CN¥0.25 in 1Q 2023). Revenue: CN¥4.43b (up 4.1% from 1Q 2023). Net income: CN¥216.2m (down 48% from 1Q 2023). Profit margin: 4.9% (down from 9.8% in 1Q 2023). Revenue is forecast to grow 14% p.a. on average during the next 3 years, compared to a 16% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 7% per year whereas the company’s share price has fallen by 9% per year.お知らせ • Mar 30Sinoma Science & Technology Co.,Ltd. to Report Q1, 2024 Results on Apr 26, 2024Sinoma Science & Technology Co.,Ltd. announced that they will report Q1, 2024 results on Apr 26, 2024お知らせ • Mar 23Sinoma Science & Technology Co.,Ltd., Annual General Meeting, Apr 12, 2024Sinoma Science & Technology Co.,Ltd., Annual General Meeting, Apr 12, 2024, at 14:00 China Standard Time. Location: The Company's Meeting Room, Beijing China Agenda: To consider 2023 annual report and its summary; to consider 2023 work report of the board of directors; to consider 2023 work report of the supervisory committee; to consider 2023 annual accounts report; to consider 2023 profit distribution plan; to consider 2024 estimated continuing connected transactions; to consider Amendments to the system for independent directors; to consider Amendments to the Company's articles of association; to consider 2024 loan budget and authorization for relevant loans; to consider Application for registration and issuance of not more than CNY 4.8 billion super and short-term commercial papers at a proper time; to consider Application for registration and issuance of not more than CNY 0.9 billion commercial papers; to consider Reappointment of 2024 audit firm; to consider Election of Wang Li as a supervisor.Reported Earnings • Mar 22Full year 2023 earnings released: EPS: CN¥1.33 (vs CN¥2.09 in FY 2022)Full year 2023 results: EPS: CN¥1.33 (down from CN¥2.09 in FY 2022). Revenue: CN¥25.9b (up 17% from FY 2022). Net income: CN¥2.22b (down 37% from FY 2022). Profit margin: 8.6% (down from 16% in FY 2022). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 14% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 2% per year but the company’s share price has fallen by 14% per year, which means it is significantly lagging earnings.Buy Or Sell Opportunity • Feb 06Now 29% overvaluedOver the last 90 days, the stock has fallen 21% to CN¥13.94. The fair value is estimated to be CN¥10.77, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 7.7% over the last 3 years. Earnings per share has grown by 11%. Revenue is forecast to grow by 49% in 2 years. Earnings are forecast to grow by 46% in the next 2 years.Valuation Update With 7 Day Price Move • Feb 05Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to CN¥12.68, the stock trades at a forward P/E ratio of 7x. Average forward P/E is 12x in the Chemicals industry in China. Total loss to shareholders of 40% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥10.87 per share.お知らせ • Dec 30Sinoma Science & Technology Co.,Ltd. to Report Fiscal Year 2023 Results on Mar 22, 2024Sinoma Science & Technology Co.,Ltd. announced that they will report fiscal year 2023 results on Mar 22, 2024Reported Earnings • Oct 24Third quarter 2023 earnings released: EPS: CN¥0.19 (vs CN¥0.33 in 3Q 2022)Third quarter 2023 results: EPS: CN¥0.19 (down from CN¥0.33 in 3Q 2022). Revenue: CN¥5.85b (up 22% from 3Q 2022). Net income: CN¥316.2m (down 42% from 3Q 2022). Profit margin: 5.4% (down from 11% in 3Q 2022). Revenue is forecast to grow 18% p.a. on average during the next 3 years, compared to a 19% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 11% per year but the company’s share price has fallen by 7% per year, which means it is significantly lagging earnings.New Risk • Aug 23New minor risk - Financial positionThe company has a high level of debt. Net debt to equity ratio: 40% This is considered a minor risk. Having a high level of debt increases the company's balance sheet risk. The company has a higher interest repayment burden, leading to the need to allocate a greater amount of its earnings towards servicing the debt, potentially limiting growth options or shareholder distributions. It can also increase the risk of bankruptcy if business conditions deteriorate enough that the company can no longer meet its debt obligations. Currently, the following risks have been identified for the company: Major Risk High level of non-cash earnings (20% accrual ratio). Minor Risks High level of debt (40% net debt to equity). Paying a dividend despite having no free cash flows.New Risk • Aug 19New major risk - Earnings qualityThe company has a high level of non-cash earnings. Accrual ratio: 20% This is considered a major risk. Non-cash earnings can arise from many different things. However, if a company consistently has a high level of non-cash earnings, it may be a sign that they are recognizing revenue from customers before the full value of the sales are received as cash or they are not depreciating the value of their assets appropriately. These are practices that inflate earnings, while not providing a similar increase to cash flows. Companies in some select industries naturally have a high level of non-cash earnings and it is not a major concern. However, in the worst case scenario it can be an early sign of performance manipulation by management. Currently, the following risks have been identified for the company: Major Risk High level of non-cash earnings (20% accrual ratio). Minor Risk Paying a dividend despite having no free cash flows.Reported Earnings • Aug 18Second quarter 2023 earnings released: EPS: CN¥0.58 (vs CN¥0.68 in 2Q 2022)Second quarter 2023 results: EPS: CN¥0.58 (down from CN¥0.68 in 2Q 2022). Revenue: CN¥8.12b (up 55% from 2Q 2022). Net income: CN¥973.4m (down 14% from 2Q 2022). Profit margin: 12% (down from 22% in 2Q 2022). Revenue is forecast to grow 17% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 19% per year but the company’s share price has only increased by 3% per year, which means it is significantly lagging earnings growth.Reported Earnings • Aug 18Second quarter 2023 earnings released: EPS: CN¥0.58 (vs CN¥0.68 in 2Q 2022)Second quarter 2023 results: EPS: CN¥0.58 (down from CN¥0.68 in 2Q 2022). Revenue: CN¥8.12b (up 55% from 2Q 2022). Net income: CN¥973.4m (down 14% from 2Q 2022). Profit margin: 12% (down from 22% in 2Q 2022). Revenue is forecast to grow 17% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 19% per year but the company’s share price has only increased by 3% per year, which means it is significantly lagging earnings growth.お知らせ • Jul 01Sinoma Science & Technology Co.,Ltd. to Report First Half, 2023 Results on Aug 18, 2023Sinoma Science & Technology Co.,Ltd. announced that they will report first half, 2023 results on Aug 18, 2023お知らせ • May 25Sinoma Science & Technology Co.,Ltd. Announces Final Dividend on A Shares for the Year 2022, Payable on May 31, 2023Sinoma Science & Technology Co.,Ltd. announced final cash dividend/10 shares (tax included) of CNY 6.60000000 on A shares for the year 2022. Record date is May 30, 2023. Ex-date is May 31, 2023. Payment date is May 31, 2023.Valuation Update With 7 Day Price Move • Apr 26Investor sentiment deteriorates as stock falls 19%After last week's 19% share price decline to CN¥20.07, the stock trades at a forward P/E ratio of 9x. Average forward P/E is 14x in the Chemicals industry in China. Total returns to shareholders of 78% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥8.97 per share.Valuation Update With 7 Day Price Move • Mar 24Investor sentiment improves as stock rises 16%After last week's 16% share price gain to CN¥24.89, the stock trades at a forward P/E ratio of 12x. Average forward P/E is 16x in the Chemicals industry in China. Total returns to shareholders of 130% over the past three years.Reported Earnings • Mar 18Full year 2022 earnings released: EPS: CN¥2.09 (vs CN¥2.01 in FY 2021)Full year 2022 results: EPS: CN¥2.09 (up from CN¥2.01 in FY 2021). Revenue: CN¥22.1b (up 8.9% from FY 2021). Net income: CN¥3.51b (up 4.1% from FY 2021). Profit margin: 16% (in line with FY 2021). Revenue is forecast to grow 15% p.a. on average during the next 2 years, compared to a 19% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 31% per year but the company’s share price has only increased by 23% per year, which means it is significantly lagging earnings growth.Board Change • Nov 16High number of new directorsThere are 6 new directors who have joined the board in the last 3 years. Independent Director Zhimeng Liu was the last director to join the board, commencing their role in 2022. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model.Reported Earnings • Oct 28Third quarter 2022 earnings released: EPS: CN¥0.33 (vs CN¥0.48 in 3Q 2021)Third quarter 2022 results: EPS: CN¥0.33 (down from CN¥0.48 in 3Q 2021). Revenue: CN¥4.78b (down 9.5% from 3Q 2021). Net income: CN¥546.4m (down 32% from 3Q 2021). Profit margin: 11% (down from 15% in 3Q 2021). Revenue is forecast to grow 15% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 36% per year but the company’s share price has only increased by 28% per year, which means it is significantly lagging earnings growth.Reported Earnings • Aug 19Second quarter 2022 earnings released: EPS: CN¥0.68 (vs CN¥0.76 in 2Q 2021)Second quarter 2022 results: EPS: CN¥0.68 (down from CN¥0.76 in 2Q 2021). Revenue: CN¥5.26b (down 2.9% from 2Q 2021). Net income: CN¥1.14b (down 10% from 2Q 2021). Profit margin: 22% (down from 23% in 2Q 2021). Over the next year, revenue is forecast to grow 20%, compared to a 41% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 40% per year whereas the company’s share price has increased by 39% per year.Valuation Update With 7 Day Price Move • Jul 21Investor sentiment improved over the past weekAfter last week's 16% share price gain to CN¥31.67, the stock trades at a forward P/E ratio of 13x. Average forward P/E is 17x in the Chemicals industry in China. Total returns to shareholders of 223% over the past three years.Reported Earnings • Apr 27First quarter 2022 earnings released: EPS: CN¥0.44 (vs CN¥0.35 in 1Q 2021)First quarter 2022 results: EPS: CN¥0.44 (up from CN¥0.35 in 1Q 2021). Revenue: CN¥4.66b (up 16% from 1Q 2021). Net income: CN¥734.4m (up 25% from 1Q 2021). Profit margin: 16% (up from 15% in 1Q 2021). Over the next year, revenue is forecast to grow 15%, compared to a 43% growth forecast for the industry in China. Over the last 3 years on average, earnings per share has increased by 44% per year but the company’s share price has only increased by 25% per year, which means it is significantly lagging earnings growth.Board Change • Apr 27High number of new directorsThere are 5 new directors who have joined the board in the last 3 years. Non-Independent Director Chang Zhangli was the last director to join the board, commencing their role in 2022. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model.Reported Earnings • Mar 19Full year 2021 earnings: Revenues and EPS in line with analyst expectationsFull year 2021 results: EPS: CN¥2.01 (up from CN¥1.22 in FY 2020). Revenue: CN¥20.3b (up 8.5% from FY 2020). Net income: CN¥3.37b (up 64% from FY 2020). Profit margin: 17% (up from 11% in FY 2020). The increase in margin was driven by higher revenue. Revenue was in line with analyst estimates. Over the next year, revenue is forecast to grow 12%, compared to a 44% growth forecast for the industry in China. Over the last 3 years on average, earnings per share has increased by 45% per year but the company’s share price has only increased by 31% per year, which means it is significantly lagging earnings growth.Board Change • Feb 02High number of new directorsThere are 5 new directors who have joined the board in the last 3 years. Non-Independent Director Chang Zhangli was the last director to join the board, commencing their role in 2022. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model.Valuation Update With 7 Day Price Move • Nov 23Investor sentiment improved over the past weekAfter last week's 17% share price gain to CN¥37.25, the stock trades at a forward P/E ratio of 16x. Average forward P/E is 21x in the Chemicals industry in China. Total returns to shareholders of 551% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥67.24 per share.Reported Earnings • Oct 20Third quarter 2021 earnings released: EPS CN¥0.48 (vs CN¥0.37 in 3Q 2020)The company reported a decent third quarter result with improved earnings and profit margins, although revenues were flat. Third quarter 2021 results: Revenue: CN¥5.28b (flat on 3Q 2020). Net income: CN¥800.4m (up 28% from 3Q 2020). Profit margin: 15% (up from 12% in 3Q 2020). Over the last 3 years on average, earnings per share has increased by 44% per year but the company’s share price has increased by 79% per year, which means it is tracking significantly ahead of earnings growth.Valuation Update With 7 Day Price Move • Sep 29Investor sentiment deteriorated over the past weekAfter last week's 17% share price decline to CN¥37.22, the stock trades at a forward P/E ratio of 17x. Average forward P/E is 20x in the Chemicals industry in China. Total returns to shareholders of 579% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥67.33 per share.Valuation Update With 7 Day Price Move • Sep 08Investor sentiment improved over the past weekAfter last week's 26% share price gain to CN¥35.92, the stock trades at a forward P/E ratio of 17x. Average forward P/E is 21x in the Chemicals industry in China. Total returns to shareholders of 563% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥61.54 per share.Reported Earnings • Aug 19Second quarter 2021 earnings released: EPS CN¥0.76 (vs CN¥0.41 in 2Q 2020)The company reported a strong second quarter result with improved earnings, revenues and profit margins. Second quarter 2021 results: Revenue: CN¥5.42b (up 15% from 2Q 2020). Net income: CN¥1.27b (up 86% from 2Q 2020). Profit margin: 23% (up from 14% in 2Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 43% per year but the company’s share price has increased by 65% per year, which means it is tracking significantly ahead of earnings growth.Valuation Update With 7 Day Price Move • Jun 24Investor sentiment improved over the past weekAfter last week's 18% share price gain to CN¥23.86, the stock trades at a forward P/E ratio of 13x. Average forward P/E is 19x in the Chemicals industry in China. Total returns to shareholders of 298% over the past three years.Reported Earnings • Apr 25First quarter 2021 earnings released: EPS CN¥0.35 (vs CN¥0.14 in 1Q 2020)The company reported a strong first quarter result with improved earnings, revenues and profit margins. First quarter 2021 results: Revenue: CN¥3.94b (up 36% from 1Q 2020). Net income: CN¥580.7m (up 140% from 1Q 2020). Profit margin: 15% (up from 8.4% in 1Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 38% per year whereas the company’s share price has increased by 37% per year.お知らせ • Mar 20Sinoma Science & Technology Co., Ltd. Announces Profit Distribution Proposal for 2020Sinoma Science & Technology Co., Ltd. announced profit distribution proposal of CNY 4.00000000 per 10 shares (tax included) for 2020.お知らせ • Mar 19Sinoma Science & Technology Co., Ltd., Annual General Meeting, Apr 08, 2021Sinoma Science & Technology Co., Ltd., Annual General Meeting, Apr 08, 2021, at 14:00 China Standard Time. Agenda: To consider the 2020 annual report and its summary; to consider the 2020 work report of the board of directors; to consider the 2020 work report of the supervisory committee; to consider the 2020 annual accounts; to consider the 2020 profit distribution plan; to consider the 2021 estimated continuing connected transactions; to consider the 2021 loan budget and authorization for relevant loans; to consider the change of the guarantee period for subsidiaries; to consider the application for registration and issuance of commercial papers; to consider the application for registration and public issuance of green corporate bonds; and to consider the provision of guarantee for a company and mutual guarantee between the company and its subsidiaries.Reported Earnings • Mar 04Full year 2020 earnings released: EPS CN¥1.22 (vs CN¥0.80 in FY 2019)The company reported a strong full year result with improved earnings, revenues and profit margins. Full year 2020 results: Revenue: CN¥18.7b (up 38% from FY 2019). Net income: CN¥2.05b (up 53% from FY 2019). Profit margin: 11% (up from 9.9% in FY 2019). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 35% per year whereas the company’s share price has increased by 30% per year.Analyst Estimate Surprise Post Earnings • Mar 04Revenue beats expectationsRevenue exceeded analyst estimates by 8.8%. Over the next year, revenue is forecast to grow 1.2%, compared to a 51% growth forecast for the Chemicals industry in China.お知らせ • Feb 18Sinoma Science & Technology Co., Ltd. to Report Fiscal Year 2020 Results on Mar 18, 2021Sinoma Science & Technology Co., Ltd. announced that they will report fiscal year 2020 results on Mar 18, 2021お知らせ • Jan 08Sinoma Science & Technology Co., Ltd. Approves Management ChangesSinoma Science & Technology Co., Ltd. at its EGM held on January 5, 2021 approved the Election of Huang Zaiman and Zhang Qi as directors and Cao Qinming as a supervisor.Valuation Update With 7 Day Price Move • Jan 07Investor sentiment improved over the past weekAfter last week's 16% share price gain to CN¥28.05, the stock is trading at a trailing P/E ratio of 25.2x, up from the previous P/E ratio of 21.7x. This compares to an average P/E of 36x in the Chemicals industry in China. Total returns to shareholders over the past three years are 151%.Is New 90 Day High Low • Dec 25New 90-day high: CN¥23.38The company is up 20% from its price of CN¥19.48 on 25 September 2020. The Chinese market is up 5.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 10.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥42.63 per share.Valuation Update With 7 Day Price Move • Dec 22Investor sentiment improved over the past weekAfter last week's 15% share price gain to CN¥22.23, the stock is trading at a trailing P/E ratio of 20x, up from the previous P/E ratio of 17.3x. This compares to an average P/E of 36x in the Chemicals industry in China. Total returns to shareholders over the past three years are 91%.お知らせ • Oct 16Sinoma Science & Technology Co., Ltd. to Report Q3, 2020 Results on Oct 22, 2020Sinoma Science & Technology Co., Ltd. announced that they will report Q3, 2020 results on Oct 22, 2020Valuation Update With 7 Day Price Move • Oct 14Market bids up stock over the past weekAfter last week's 16% share price gain to CN¥23.15, the stock is trading at a trailing P/E ratio of 24.2x, up from the previous P/E ratio of 20.9x. This compares to an average P/E of 40x in the Chemicals industry in China. Total returns to shareholders over the past three years are 98%.Is New 90 Day High Low • Oct 14New 90-day high: CN¥23.15The company is up 31% from its price of CN¥17.67 on 16 July 2020. The Chinese market is flat over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 9.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥30.18 per share.お知らせ • Jul 24Sinoma Science & Technology Co., Ltd. to Report First Half, 2020 Results on Aug 20, 2020Sinoma Science & Technology Co., Ltd. announced that they will report first half, 2020 results on Aug 20, 2020決済の安定と成長配当データの取得安定した配当: 002080の配当金支払いは、過去10年間 変動性 が高かった。増加する配当: 002080の配当金は過去10年間にわたって増加しています。配当利回り対市場Sinoma Science & TechnologyLtd 配当利回り対市場002080 配当利回りは市場と比べてどうか？セグメント配当利回り会社 (002080)0.6%市場下位25% (CN)0.4%市場トップ25% (CN)1.9%業界平均 (Chemicals)1.2%アナリスト予想 (002080) (最長3年)1.0%注目すべき配当: 002080の配当金 ( 0.61% ) はCN市場の配当金支払者の下位 25% ( 0.37% ) よりも高くなっています。高配当: 002080の配当金 ( 0.61% ) はCN市場の配当金支払者の上位 25% ( 1.93% ) と比較すると低いです。株主への利益配当収益カバレッジ: 002080の 配当性向 ( 37.1% ) はかなり低いため、配当金の支払いは利益によって十分にカバーされます。株主配当金キャッシュフローカバレッジ: 002080は高い 現金配当性向 ( 210.5% ) のため、配当金の支払いはキャッシュフローで十分にカバーされていません。高配当企業の発掘7D1Y7D1Y7D1YCN 市場の強力な配当支払い企業。View Management企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/05/22 14:51終値2026/05/22 00:00収益2026/03/31年間収益2025/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Sinoma Science & Technology Co.,Ltd. 5 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。13 アナリスト機関Edward LeungBofA Global ResearchJiachen LiuChina International Capital Corporation LimitedSophia ZhangChina Stock Investment Research Co. Ltd. (GZ500..com)10 その他のアナリストを表示
Declared Dividend • May 27Dividend reduced to CN¥0.56Dividend of CN¥0.56 is 15% lower than last year. Ex-date: 31st May 2024 Payment date: 31st May 2024 Dividend yield will be 3.6%, which is higher than the industry average of 2.6%. Sustainability & Growth Dividend is covered by earnings (46% earnings payout ratio) but the company has no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has increased by an average of 28% per year over the past 10 years. However, payments have been volatile during that time. EPS is expected to grow by 66% over the next 3 years, which should provide support to the dividend and adequate earnings cover.
お知らせ • May 26Sinoma Science & Technology Co.,Ltd. Announces Final Cash Dividend on A Shares for 2023, Payable on 31 May 2024Sinoma Science & Technology Co.,Ltd. announced 2023 final profit distribution plan to be implemented (A shares): Cash dividend/10 shares (tax included): CNY 5.60000000. Record date: 30 May 2024; Ex-date: 31 May 2024; Payment date: 31 May 2024.
お知らせ • May 25Sinoma Science & Technology Co.,Ltd. Announces Final Dividend on A Shares for the Year 2022, Payable on May 31, 2023Sinoma Science & Technology Co.,Ltd. announced final cash dividend/10 shares (tax included) of CNY 6.60000000 on A shares for the year 2022. Record date is May 30, 2023. Ex-date is May 31, 2023. Payment date is May 31, 2023.
お知らせ • Mar 20Sinoma Science & Technology Co., Ltd. Announces Profit Distribution Proposal for 2020Sinoma Science & Technology Co., Ltd. announced profit distribution proposal of CNY 4.00000000 per 10 shares (tax included) for 2020.
Board Change • May 20Less than half of directors are independentThere are 5 new directors who have joined the board in the last 3 years. Of these new board members, 1 was an independent director. The company's board is composed of: 3 independent directors. 4 non-independent directors. Independent Director Guanyu Wang was the last independent director to join the board, commencing their role in 2024. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of board continuity.
お知らせ • Mar 31Sinoma Science & Technology Co.,Ltd. to Report Q1, 2026 Results on Apr 24, 2026Sinoma Science & Technology Co.,Ltd. announced that they will report Q1, 2026 results on Apr 24, 2026
お知らせ • Mar 19Sinoma Science & Technology Co.,Ltd., Annual General Meeting, Apr 09, 2026Sinoma Science & Technology Co.,Ltd., Annual General Meeting, Apr 09, 2026, at 16:30 China Standard Time. Location: 12F, Building 7, Yard No. 6, North Street, Dongsheng Science and Technology Park, Haidian District, Beijing China
お知らせ • Dec 31Sinoma Science & Technology Co.,Ltd. to Report Fiscal Year 2025 Results on Mar 20, 2026Sinoma Science & Technology Co.,Ltd. announced that they will report fiscal year 2025 results on Mar 20, 2026
お知らせ • Sep 30+ 2 more updatesSinoma Science & Technology Co.,Ltd. to Report Q3, 2025 Results on Oct 22, 2025Sinoma Science & Technology Co.,Ltd. announced that they will report Q3, 2025 results on Oct 22, 2025
お知らせ • Jul 02Sinoma Science & Technology Co.,Ltd. to Report First Half, 2025 Results on Aug 22, 2025Sinoma Science & Technology Co.,Ltd. announced that they will report first half, 2025 results on Aug 22, 2025
お知らせ • Apr 12+ 1 more updateSinoma Science & Technology Co.,Ltd. Approves the Election of Ni Jinrui as DirectorSinoma Science & Technology Co.,Ltd. at its Annual General Meeting held on 10 April 2025 approved the election of Ni Jinrui as a director.
お知らせ • Mar 31Sinoma Science & Technology Co.,Ltd. to Report Q1, 2025 Results on Apr 24, 2025Sinoma Science & Technology Co.,Ltd. announced that they will report Q1, 2025 results on Apr 24, 2025
お知らせ • Mar 20Sinoma Science & Technology Co.,Ltd., Annual General Meeting, Apr 10, 2025Sinoma Science & Technology Co.,Ltd., Annual General Meeting, Apr 10, 2025, at 16:30 China Standard Time. Location: The Company's Meeting Room, Beijing China
お知らせ • Dec 31Sinoma Science & Technology Co.,Ltd. to Report Fiscal Year 2024 Results on Mar 20, 2025Sinoma Science & Technology Co.,Ltd. announced that they will report fiscal year 2024 results on Mar 20, 2025
お知らせ • Nov 15Sinoma Science & Technology Co.,Ltd. Appoints Feng Jun as DirectorSinoma Science & Technology Co.,Ltd. held its 4th Extraordinary General Meeting of 2024 on 13 November 2024 were approved; Election of Feng Jun as a director.
Reported Earnings • Oct 26Third quarter 2024 earnings released: EPS: CN¥0.086 (vs CN¥0.19 in 3Q 2023)Third quarter 2024 results: EPS: CN¥0.086 (down from CN¥0.19 in 3Q 2023). Revenue: CN¥6.27b (up 7.1% from 3Q 2023). Net income: CN¥143.7m (down 55% from 3Q 2023). Profit margin: 2.3% (down from 5.4% in 3Q 2023). Revenue is forecast to grow 16% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 26% per year whereas the company’s share price has fallen by 30% per year.
お知らせ • Sep 30Sinoma Science & Technology Co.,Ltd. to Report Q3, 2024 Results on Oct 25, 2024Sinoma Science & Technology Co.,Ltd. announced that they will report Q3, 2024 results on Oct 25, 2024
Valuation Update With 7 Day Price Move • Sep 28Investor sentiment improves as stock rises 22%After last week's 22% share price gain to CN¥11.61, the stock trades at a forward P/E ratio of 12x. Average forward P/E is 16x in the Chemicals industry in China. Total loss to shareholders of 64% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥8.71 per share.
Buy Or Sell Opportunity • Sep 26Now 24% overvaluedOver the last 90 days, the stock has fallen 16% to CN¥10.86. The fair value is estimated to be CN¥8.73, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 8.7% over the last 3 years. Earnings per share has declined by 17%. Revenue is forecast to grow by 35% in 2 years. Earnings are forecast to grow by 70% in the next 2 years.
お知らせ • Sep 11Sinoma Science & Technology Co.,Ltd. Approves Board ElectionsSinoma Science & Technology Co.,Ltd. at its EGM held on September 9, 2024 approved election of Zhuang Qinxia as director and Wang Guanyu as independent director.
Reported Earnings • Aug 22Second quarter 2024 earnings released: EPS: CN¥0.15 (vs CN¥0.58 in 2Q 2023)Second quarter 2024 results: EPS: CN¥0.15 (down from CN¥0.58 in 2Q 2023). Revenue: CN¥6.11b (down 17% from 2Q 2023). Net income: CN¥248.4m (down 75% from 2Q 2023). Profit margin: 4.1% (down from 13% in 2Q 2023). Revenue is forecast to grow 15% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 17% per year but the company’s share price has fallen by 30% per year, which means it is performing significantly worse than earnings.
お知らせ • Jun 29Sinoma Science & Technology Co.,Ltd. to Report First Half, 2024 Results on Aug 22, 2024Sinoma Science & Technology Co.,Ltd. announced that they will report first half, 2024 results on Aug 22, 2024
Declared Dividend • May 27Dividend reduced to CN¥0.56Dividend of CN¥0.56 is 15% lower than last year. Ex-date: 31st May 2024 Payment date: 31st May 2024 Dividend yield will be 3.6%, which is higher than the industry average of 2.6%. Sustainability & Growth Dividend is covered by earnings (46% earnings payout ratio) but the company has no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has increased by an average of 28% per year over the past 10 years. However, payments have been volatile during that time. EPS is expected to grow by 66% over the next 3 years, which should provide support to the dividend and adequate earnings cover.
お知らせ • May 26Sinoma Science & Technology Co.,Ltd. Announces Final Cash Dividend on A Shares for 2023, Payable on 31 May 2024Sinoma Science & Technology Co.,Ltd. announced 2023 final profit distribution plan to be implemented (A shares): Cash dividend/10 shares (tax included): CNY 5.60000000. Record date: 30 May 2024; Ex-date: 31 May 2024; Payment date: 31 May 2024.
お知らせ • May 15Sinoma Science & Technology Co.,Ltd. Elects Zhang Wenjin as a DirectorSinoma Science & Technology Co.,Ltd. held its first Extraordinary General Meeting of 2024 on 13 May 2024, elected Zhang Wenjin as a director.
Reported Earnings • Apr 26First quarter 2024 earnings released: EPS: CN¥0.13 (vs CN¥0.25 in 1Q 2023)First quarter 2024 results: EPS: CN¥0.13 (down from CN¥0.25 in 1Q 2023). Revenue: CN¥4.43b (up 4.1% from 1Q 2023). Net income: CN¥216.2m (down 48% from 1Q 2023). Profit margin: 4.9% (down from 9.8% in 1Q 2023). Revenue is forecast to grow 14% p.a. on average during the next 3 years, compared to a 16% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 7% per year whereas the company’s share price has fallen by 9% per year.
お知らせ • Mar 30Sinoma Science & Technology Co.,Ltd. to Report Q1, 2024 Results on Apr 26, 2024Sinoma Science & Technology Co.,Ltd. announced that they will report Q1, 2024 results on Apr 26, 2024
お知らせ • Mar 23Sinoma Science & Technology Co.,Ltd., Annual General Meeting, Apr 12, 2024Sinoma Science & Technology Co.,Ltd., Annual General Meeting, Apr 12, 2024, at 14:00 China Standard Time. Location: The Company's Meeting Room, Beijing China Agenda: To consider 2023 annual report and its summary; to consider 2023 work report of the board of directors; to consider 2023 work report of the supervisory committee; to consider 2023 annual accounts report; to consider 2023 profit distribution plan; to consider 2024 estimated continuing connected transactions; to consider Amendments to the system for independent directors; to consider Amendments to the Company's articles of association; to consider 2024 loan budget and authorization for relevant loans; to consider Application for registration and issuance of not more than CNY 4.8 billion super and short-term commercial papers at a proper time; to consider Application for registration and issuance of not more than CNY 0.9 billion commercial papers; to consider Reappointment of 2024 audit firm; to consider Election of Wang Li as a supervisor.
Reported Earnings • Mar 22Full year 2023 earnings released: EPS: CN¥1.33 (vs CN¥2.09 in FY 2022)Full year 2023 results: EPS: CN¥1.33 (down from CN¥2.09 in FY 2022). Revenue: CN¥25.9b (up 17% from FY 2022). Net income: CN¥2.22b (down 37% from FY 2022). Profit margin: 8.6% (down from 16% in FY 2022). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 14% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 2% per year but the company’s share price has fallen by 14% per year, which means it is significantly lagging earnings.
Buy Or Sell Opportunity • Feb 06Now 29% overvaluedOver the last 90 days, the stock has fallen 21% to CN¥13.94. The fair value is estimated to be CN¥10.77, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 7.7% over the last 3 years. Earnings per share has grown by 11%. Revenue is forecast to grow by 49% in 2 years. Earnings are forecast to grow by 46% in the next 2 years.
Valuation Update With 7 Day Price Move • Feb 05Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to CN¥12.68, the stock trades at a forward P/E ratio of 7x. Average forward P/E is 12x in the Chemicals industry in China. Total loss to shareholders of 40% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥10.87 per share.
お知らせ • Dec 30Sinoma Science & Technology Co.,Ltd. to Report Fiscal Year 2023 Results on Mar 22, 2024Sinoma Science & Technology Co.,Ltd. announced that they will report fiscal year 2023 results on Mar 22, 2024
Reported Earnings • Oct 24Third quarter 2023 earnings released: EPS: CN¥0.19 (vs CN¥0.33 in 3Q 2022)Third quarter 2023 results: EPS: CN¥0.19 (down from CN¥0.33 in 3Q 2022). Revenue: CN¥5.85b (up 22% from 3Q 2022). Net income: CN¥316.2m (down 42% from 3Q 2022). Profit margin: 5.4% (down from 11% in 3Q 2022). Revenue is forecast to grow 18% p.a. on average during the next 3 years, compared to a 19% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 11% per year but the company’s share price has fallen by 7% per year, which means it is significantly lagging earnings.
New Risk • Aug 23New minor risk - Financial positionThe company has a high level of debt. Net debt to equity ratio: 40% This is considered a minor risk. Having a high level of debt increases the company's balance sheet risk. The company has a higher interest repayment burden, leading to the need to allocate a greater amount of its earnings towards servicing the debt, potentially limiting growth options or shareholder distributions. It can also increase the risk of bankruptcy if business conditions deteriorate enough that the company can no longer meet its debt obligations. Currently, the following risks have been identified for the company: Major Risk High level of non-cash earnings (20% accrual ratio). Minor Risks High level of debt (40% net debt to equity). Paying a dividend despite having no free cash flows.
New Risk • Aug 19New major risk - Earnings qualityThe company has a high level of non-cash earnings. Accrual ratio: 20% This is considered a major risk. Non-cash earnings can arise from many different things. However, if a company consistently has a high level of non-cash earnings, it may be a sign that they are recognizing revenue from customers before the full value of the sales are received as cash or they are not depreciating the value of their assets appropriately. These are practices that inflate earnings, while not providing a similar increase to cash flows. Companies in some select industries naturally have a high level of non-cash earnings and it is not a major concern. However, in the worst case scenario it can be an early sign of performance manipulation by management. Currently, the following risks have been identified for the company: Major Risk High level of non-cash earnings (20% accrual ratio). Minor Risk Paying a dividend despite having no free cash flows.
Reported Earnings • Aug 18Second quarter 2023 earnings released: EPS: CN¥0.58 (vs CN¥0.68 in 2Q 2022)Second quarter 2023 results: EPS: CN¥0.58 (down from CN¥0.68 in 2Q 2022). Revenue: CN¥8.12b (up 55% from 2Q 2022). Net income: CN¥973.4m (down 14% from 2Q 2022). Profit margin: 12% (down from 22% in 2Q 2022). Revenue is forecast to grow 17% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 19% per year but the company’s share price has only increased by 3% per year, which means it is significantly lagging earnings growth.
Reported Earnings • Aug 18Second quarter 2023 earnings released: EPS: CN¥0.58 (vs CN¥0.68 in 2Q 2022)Second quarter 2023 results: EPS: CN¥0.58 (down from CN¥0.68 in 2Q 2022). Revenue: CN¥8.12b (up 55% from 2Q 2022). Net income: CN¥973.4m (down 14% from 2Q 2022). Profit margin: 12% (down from 22% in 2Q 2022). Revenue is forecast to grow 17% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 19% per year but the company’s share price has only increased by 3% per year, which means it is significantly lagging earnings growth.
お知らせ • Jul 01Sinoma Science & Technology Co.,Ltd. to Report First Half, 2023 Results on Aug 18, 2023Sinoma Science & Technology Co.,Ltd. announced that they will report first half, 2023 results on Aug 18, 2023
お知らせ • May 25Sinoma Science & Technology Co.,Ltd. Announces Final Dividend on A Shares for the Year 2022, Payable on May 31, 2023Sinoma Science & Technology Co.,Ltd. announced final cash dividend/10 shares (tax included) of CNY 6.60000000 on A shares for the year 2022. Record date is May 30, 2023. Ex-date is May 31, 2023. Payment date is May 31, 2023.
Valuation Update With 7 Day Price Move • Apr 26Investor sentiment deteriorates as stock falls 19%After last week's 19% share price decline to CN¥20.07, the stock trades at a forward P/E ratio of 9x. Average forward P/E is 14x in the Chemicals industry in China. Total returns to shareholders of 78% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥8.97 per share.
Valuation Update With 7 Day Price Move • Mar 24Investor sentiment improves as stock rises 16%After last week's 16% share price gain to CN¥24.89, the stock trades at a forward P/E ratio of 12x. Average forward P/E is 16x in the Chemicals industry in China. Total returns to shareholders of 130% over the past three years.
Reported Earnings • Mar 18Full year 2022 earnings released: EPS: CN¥2.09 (vs CN¥2.01 in FY 2021)Full year 2022 results: EPS: CN¥2.09 (up from CN¥2.01 in FY 2021). Revenue: CN¥22.1b (up 8.9% from FY 2021). Net income: CN¥3.51b (up 4.1% from FY 2021). Profit margin: 16% (in line with FY 2021). Revenue is forecast to grow 15% p.a. on average during the next 2 years, compared to a 19% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 31% per year but the company’s share price has only increased by 23% per year, which means it is significantly lagging earnings growth.
Board Change • Nov 16High number of new directorsThere are 6 new directors who have joined the board in the last 3 years. Independent Director Zhimeng Liu was the last director to join the board, commencing their role in 2022. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model.
Reported Earnings • Oct 28Third quarter 2022 earnings released: EPS: CN¥0.33 (vs CN¥0.48 in 3Q 2021)Third quarter 2022 results: EPS: CN¥0.33 (down from CN¥0.48 in 3Q 2021). Revenue: CN¥4.78b (down 9.5% from 3Q 2021). Net income: CN¥546.4m (down 32% from 3Q 2021). Profit margin: 11% (down from 15% in 3Q 2021). Revenue is forecast to grow 15% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 36% per year but the company’s share price has only increased by 28% per year, which means it is significantly lagging earnings growth.
Reported Earnings • Aug 19Second quarter 2022 earnings released: EPS: CN¥0.68 (vs CN¥0.76 in 2Q 2021)Second quarter 2022 results: EPS: CN¥0.68 (down from CN¥0.76 in 2Q 2021). Revenue: CN¥5.26b (down 2.9% from 2Q 2021). Net income: CN¥1.14b (down 10% from 2Q 2021). Profit margin: 22% (down from 23% in 2Q 2021). Over the next year, revenue is forecast to grow 20%, compared to a 41% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 40% per year whereas the company’s share price has increased by 39% per year.
Valuation Update With 7 Day Price Move • Jul 21Investor sentiment improved over the past weekAfter last week's 16% share price gain to CN¥31.67, the stock trades at a forward P/E ratio of 13x. Average forward P/E is 17x in the Chemicals industry in China. Total returns to shareholders of 223% over the past three years.
Reported Earnings • Apr 27First quarter 2022 earnings released: EPS: CN¥0.44 (vs CN¥0.35 in 1Q 2021)First quarter 2022 results: EPS: CN¥0.44 (up from CN¥0.35 in 1Q 2021). Revenue: CN¥4.66b (up 16% from 1Q 2021). Net income: CN¥734.4m (up 25% from 1Q 2021). Profit margin: 16% (up from 15% in 1Q 2021). Over the next year, revenue is forecast to grow 15%, compared to a 43% growth forecast for the industry in China. Over the last 3 years on average, earnings per share has increased by 44% per year but the company’s share price has only increased by 25% per year, which means it is significantly lagging earnings growth.
Board Change • Apr 27High number of new directorsThere are 5 new directors who have joined the board in the last 3 years. Non-Independent Director Chang Zhangli was the last director to join the board, commencing their role in 2022. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model.
Reported Earnings • Mar 19Full year 2021 earnings: Revenues and EPS in line with analyst expectationsFull year 2021 results: EPS: CN¥2.01 (up from CN¥1.22 in FY 2020). Revenue: CN¥20.3b (up 8.5% from FY 2020). Net income: CN¥3.37b (up 64% from FY 2020). Profit margin: 17% (up from 11% in FY 2020). The increase in margin was driven by higher revenue. Revenue was in line with analyst estimates. Over the next year, revenue is forecast to grow 12%, compared to a 44% growth forecast for the industry in China. Over the last 3 years on average, earnings per share has increased by 45% per year but the company’s share price has only increased by 31% per year, which means it is significantly lagging earnings growth.
Board Change • Feb 02High number of new directorsThere are 5 new directors who have joined the board in the last 3 years. Non-Independent Director Chang Zhangli was the last director to join the board, commencing their role in 2022. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model.
Valuation Update With 7 Day Price Move • Nov 23Investor sentiment improved over the past weekAfter last week's 17% share price gain to CN¥37.25, the stock trades at a forward P/E ratio of 16x. Average forward P/E is 21x in the Chemicals industry in China. Total returns to shareholders of 551% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥67.24 per share.
Reported Earnings • Oct 20Third quarter 2021 earnings released: EPS CN¥0.48 (vs CN¥0.37 in 3Q 2020)The company reported a decent third quarter result with improved earnings and profit margins, although revenues were flat. Third quarter 2021 results: Revenue: CN¥5.28b (flat on 3Q 2020). Net income: CN¥800.4m (up 28% from 3Q 2020). Profit margin: 15% (up from 12% in 3Q 2020). Over the last 3 years on average, earnings per share has increased by 44% per year but the company’s share price has increased by 79% per year, which means it is tracking significantly ahead of earnings growth.
Valuation Update With 7 Day Price Move • Sep 29Investor sentiment deteriorated over the past weekAfter last week's 17% share price decline to CN¥37.22, the stock trades at a forward P/E ratio of 17x. Average forward P/E is 20x in the Chemicals industry in China. Total returns to shareholders of 579% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥67.33 per share.
Valuation Update With 7 Day Price Move • Sep 08Investor sentiment improved over the past weekAfter last week's 26% share price gain to CN¥35.92, the stock trades at a forward P/E ratio of 17x. Average forward P/E is 21x in the Chemicals industry in China. Total returns to shareholders of 563% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥61.54 per share.
Reported Earnings • Aug 19Second quarter 2021 earnings released: EPS CN¥0.76 (vs CN¥0.41 in 2Q 2020)The company reported a strong second quarter result with improved earnings, revenues and profit margins. Second quarter 2021 results: Revenue: CN¥5.42b (up 15% from 2Q 2020). Net income: CN¥1.27b (up 86% from 2Q 2020). Profit margin: 23% (up from 14% in 2Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 43% per year but the company’s share price has increased by 65% per year, which means it is tracking significantly ahead of earnings growth.
Valuation Update With 7 Day Price Move • Jun 24Investor sentiment improved over the past weekAfter last week's 18% share price gain to CN¥23.86, the stock trades at a forward P/E ratio of 13x. Average forward P/E is 19x in the Chemicals industry in China. Total returns to shareholders of 298% over the past three years.
Reported Earnings • Apr 25First quarter 2021 earnings released: EPS CN¥0.35 (vs CN¥0.14 in 1Q 2020)The company reported a strong first quarter result with improved earnings, revenues and profit margins. First quarter 2021 results: Revenue: CN¥3.94b (up 36% from 1Q 2020). Net income: CN¥580.7m (up 140% from 1Q 2020). Profit margin: 15% (up from 8.4% in 1Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 38% per year whereas the company’s share price has increased by 37% per year.
お知らせ • Mar 20Sinoma Science & Technology Co., Ltd. Announces Profit Distribution Proposal for 2020Sinoma Science & Technology Co., Ltd. announced profit distribution proposal of CNY 4.00000000 per 10 shares (tax included) for 2020.
お知らせ • Mar 19Sinoma Science & Technology Co., Ltd., Annual General Meeting, Apr 08, 2021Sinoma Science & Technology Co., Ltd., Annual General Meeting, Apr 08, 2021, at 14:00 China Standard Time. Agenda: To consider the 2020 annual report and its summary; to consider the 2020 work report of the board of directors; to consider the 2020 work report of the supervisory committee; to consider the 2020 annual accounts; to consider the 2020 profit distribution plan; to consider the 2021 estimated continuing connected transactions; to consider the 2021 loan budget and authorization for relevant loans; to consider the change of the guarantee period for subsidiaries; to consider the application for registration and issuance of commercial papers; to consider the application for registration and public issuance of green corporate bonds; and to consider the provision of guarantee for a company and mutual guarantee between the company and its subsidiaries.
Reported Earnings • Mar 04Full year 2020 earnings released: EPS CN¥1.22 (vs CN¥0.80 in FY 2019)The company reported a strong full year result with improved earnings, revenues and profit margins. Full year 2020 results: Revenue: CN¥18.7b (up 38% from FY 2019). Net income: CN¥2.05b (up 53% from FY 2019). Profit margin: 11% (up from 9.9% in FY 2019). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 35% per year whereas the company’s share price has increased by 30% per year.
Analyst Estimate Surprise Post Earnings • Mar 04Revenue beats expectationsRevenue exceeded analyst estimates by 8.8%. Over the next year, revenue is forecast to grow 1.2%, compared to a 51% growth forecast for the Chemicals industry in China.
お知らせ • Feb 18Sinoma Science & Technology Co., Ltd. to Report Fiscal Year 2020 Results on Mar 18, 2021Sinoma Science & Technology Co., Ltd. announced that they will report fiscal year 2020 results on Mar 18, 2021
お知らせ • Jan 08Sinoma Science & Technology Co., Ltd. Approves Management ChangesSinoma Science & Technology Co., Ltd. at its EGM held on January 5, 2021 approved the Election of Huang Zaiman and Zhang Qi as directors and Cao Qinming as a supervisor.
Valuation Update With 7 Day Price Move • Jan 07Investor sentiment improved over the past weekAfter last week's 16% share price gain to CN¥28.05, the stock is trading at a trailing P/E ratio of 25.2x, up from the previous P/E ratio of 21.7x. This compares to an average P/E of 36x in the Chemicals industry in China. Total returns to shareholders over the past three years are 151%.
Is New 90 Day High Low • Dec 25New 90-day high: CN¥23.38The company is up 20% from its price of CN¥19.48 on 25 September 2020. The Chinese market is up 5.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 10.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥42.63 per share.
Valuation Update With 7 Day Price Move • Dec 22Investor sentiment improved over the past weekAfter last week's 15% share price gain to CN¥22.23, the stock is trading at a trailing P/E ratio of 20x, up from the previous P/E ratio of 17.3x. This compares to an average P/E of 36x in the Chemicals industry in China. Total returns to shareholders over the past three years are 91%.
お知らせ • Oct 16Sinoma Science & Technology Co., Ltd. to Report Q3, 2020 Results on Oct 22, 2020Sinoma Science & Technology Co., Ltd. announced that they will report Q3, 2020 results on Oct 22, 2020
Valuation Update With 7 Day Price Move • Oct 14Market bids up stock over the past weekAfter last week's 16% share price gain to CN¥23.15, the stock is trading at a trailing P/E ratio of 24.2x, up from the previous P/E ratio of 20.9x. This compares to an average P/E of 40x in the Chemicals industry in China. Total returns to shareholders over the past three years are 98%.
Is New 90 Day High Low • Oct 14New 90-day high: CN¥23.15The company is up 31% from its price of CN¥17.67 on 16 July 2020. The Chinese market is flat over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 9.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥30.18 per share.
お知らせ • Jul 24Sinoma Science & Technology Co., Ltd. to Report First Half, 2020 Results on Aug 20, 2020Sinoma Science & Technology Co., Ltd. announced that they will report first half, 2020 results on Aug 20, 2020